Prenetics
PublicPrenetics is now publicly traded
The data on this page reflects Prenetics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Strategic
Nov 5, 2026
Total Funding Raised
$1B
Company Overview
Prenetics is a health sciences company that specializes in consumer and clinical health solutions, including multi-cancer early detection technologies, advanced genomic profiling, and wellness products.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Prenetics Comparables
Compare Prenetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Living DNA | 61% | |
| L-Nutra | 58% | |
| Agen Genomics, Inc. | 56% |
For institutional investors. Book with your work email.
Prenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 5, 2026 | ||||
| Growth Equity | Jul 14, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Catalyst's Customer Value Fund | Growth Equity |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 5, 2026
Prenetics partners with Authentic Brands Group in a 10-year exclusive worldwide partnership to build Care Bears by IM8, with IM8 serving as exclusive operating partner and a global gummy multivitamin launch targeted for H1 '27, announced on Nov 5th '26.
For institutional investors. Book with your work email.
Prenetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.